logo

Sheel Biotech ₹34.02 Crore IPO Opens Today; Raises ₹9.6 Crore From Anchor Investors

By Shishta Dutta | Published at: Sep 30, 2025 10:00 AM IST

Sheel Biotech ₹34.02 Crore IPO Opens Today; Raises ₹9.6 Crore From Anchor Investors
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

New Delhi, September 30, 2025: The ₹34.02 crore Initial Public Offering (IPO) of Sheel Biotech Limited IPO is set to open today, on September 30. Investors who want to apply to the issue can do so by logging in to their net banking portal and applying through the ASBA facility. They can also use a UPI mandate to apply through their stock broking app. The IPO application window will remain open till October 3.

Sheel Biotech Limited is engaged in tissue culture, organic farming, greenhouse projects, farmer training, and landscaping services. The company was founded in 1991 and is headquartered in New Delhi.

Sheel Biotech IPO Raised ₹9.6 Crore From Anchor Investors

Ahead of the IPO, the company raised ₹9.6 crore from 5 anchor investors by allocating them 15.24 lakh equity shares at ₹63 per share. Key investors included Bharat Venture Opportunities Fund, Aarth AIF Growth Fund, Saint Capital Fund, VBCube Ventures Fund, and Sanshi Fund – 1.

Sheel Biotech IPO Issue Size of ₹34.02 Crore

The IPO has an issue size of ₹34.02 crore, including an entirely fresh issue of 54,00,000 shares, with no offer for sale element. The company has set a price band of ₹59 to ₹63 per share. The lot size for an application is 2,000. The minimum amount of investment required by an individual investor (retail) is ₹2,52,000.00 (4,000 shares) (based on upper price). The minimum lot size investment for HNI is 3 lots (6,000 shares), amounting to ₹3,78,000.

Narnolia Financial Services Ltd. is the book-running lead manager, and Skyline Financial Services Pvt.Ltd is the registrar of the issue. The shares are expected to list on BSE SME on October 8, 2025.

Sheel Biotech IPO Working Capital Main Fundraising Motive

The company will use ₹15.88 crore for working capital requirements, ₹9.12 crore for capital expenditure (including expansion into blueberry cultivation), and the balance for general corporate purposes.

Sheel Biotech IPO Revenue From Operations At ₹8,011.57 Crore

In FY25, the company’s revenue for operations stood at ₹10,175.25 crore, which was ₹9,228.22 crore in FY24 and ₹8,011.57 crore in FY23. Profit after tax in FY25 was ₹1,063.61 crore, up from ₹1,047.47 crore in FY24 and ₹507.65 crore in FY23. Net worth increased from ₹6,354.15 crore in FY23 to ₹7,269.02 crore in FY24 and to ₹8,385.42 crore in FY25. EPS in FY25 was at ₹7.21, which was ₹7.22 in FY24, and ₹3.50 in FY23.

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy